Anna Staniszewska
8PUBLICATIONS
111CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.Anton Safonov, Minna Lee, David N Brown
|Jan 28, 2026
An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance.Elsa Irving, Alaide Morcavallo, Jekaterina Vohhodina-Tretjakova
|Jan 25, 2025
NF-κB-Inducing Kinase Is Essential for Effective c-Rel Transactivation and Binding to the Il12b Promoter in Macrophages.Natalia Cuesta, Anna D Staniszewska, Cristóbal Moreno
|Nov 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.Anna D Staniszewska, Domenic Pilger, Sonja J Gill
|Mar 30, 2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.Giulia Dellavedova, Alessandra Decio, Laura Formenti
|Nov 10, 2022
Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305.Krista Kinneer, Philipp Wortmann, Zachary A Cooper
Pageof 2
Frequent Collaborators
4 joint publications
Elisabetta Leo
3 joint publications
Mark R Albertella
2 joint publications
Giuditta Illuzzi
2 joint publications
Sonja J Gill
2 joint publications
Andy Pike
2 joint publications
Lisa McWilliams
2 joint publications
Susan E Critchlow
2 joint publications
Stephen Fawell
2 joint publications
Kunzah Jamal
2 joint publications
Jeffrey W Johannes
